News

Sabin Vaccine Institute begins trial of vaccine candidate for Marburg virus disease
The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...
CIDRAP1d
Quick takes: Pandemic Accord draft finalized, H5N1 PCR test, Marburg vaccine progress
Complex Pandemic Accord negotiations have been underway since 2021, with 13 formal meetings and numerous informal sessions.
Sabin Vaccine Institute: Sabin Begins Marburg Vaccine Trial in U.S.
The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...
Sabin Begins Marburg Vaccine Trial in U.S.
The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...
Health and Me on MSN2d
Disease X Is A Deadlier Threat Than COVID: 4 Viruses That Could Spark The Next Pandemic
The UK Health Security Agency identified four virus families—some deadlier than COVID-19—with high pandemic potential. One, ...
Science Daily3d
A mysterious pathogen: Oropouche virus more common in Latin America than previously thought
Like the dengue and Zika viruses, Oropouche virus causes a febrile illness. There are recent indications that infections during pregnancy can cause damage to unborn babies. Researchers have now ...
Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
WHO working group makes progress on pandemic preparedness plan
World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...